SCHEMBL20865634

SCHEMBL20865634

CCCCN(C)CCN(C)CCC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.43
CA12 O43570 1/20 0.42
CA2 P00918 1/20 0.42
CA3 P07451 1/20 0.42
CA4 P22748 1/20 0.42
CA6 P23280 1/20 0.42
CA5A P35218 1/20 0.42
CA7 P43166 1/20 0.42
CA9 Q16790 1/20 0.42
CA14 Q9ULX7 1/20 0.42
CA5B Q9Y2D0 1/20 0.42
S1PR2 O95136 1/20 0.41
S1PR1 P21453 1/20 0.41
S1PR3 Q99500 1/20 0.41
S1PR5 Q9H228 1/20 0.41
DNM1 Q05193 3/20 0.41
KDM4C Q9H3R0 7/20 0.41
KDM5A P29375 5/20 0.41
CHRM2 P08172 1/20 0.39
KDM4A O75164 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL153410 0.97
Hydrochloric Acid SCHEMBL22771660 0.94 DNM1 (0.46) SIGMAR1S1PR2S1PR1S1PR3S1PR5
SCHEMBL9188133 0.94 CA12 (0.47) CA12CA2CA3CA4CA6
SCHEMBL29580877 0.94 CA12 (0.47) CA12CA2CA3CA4CA6
SCHEMBL29581377 0.94 CA12 (0.47) CA12CA2CA3CA4CA6
SCHEMBL78617 0.90 DNM1 (0.47) CA12CA2CA3CA4CA6
SCHEMBL20100974 0.89 SIGMAR1 (0.38) SIGMAR1CA12CA2CA3CA4
SCHEMBL16711579 0.88 DNM1 (0.57) SIGMAR1S1PR2S1PR1S1PR3S1PR5
SCHEMBL800193 0.88 DNM1 (0.55) SIGMAR1S1PR2S1PR1S1PR3S1PR5
SCHEMBL23945948 0.87 SIGMAR1 (0.46) SIGMAR1CA12CA2CA3CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019067974-A1 ANTI-INFLAMMATORY, ANTI-CANCER, AND ANTI-ANGIOGENIC COMPOUNDS, PHARMACEUTICALS COMPOSITIONS, AND METHODS OF MAKING AND USING THEREOF MEDICAL PHARMACEUTICALS, INC. (US) 2019-04-04 WO disclosed